Bronchiectasis natural history, complications and prognosis: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Bronchiectasis}} | {{Bronchiectasis}} | ||
== | ==Overview== | ||
Bronchiectasis shows a higher mortality with males, advanced age, poor functional status, severe disease based on radiographic findings, and evidence of hypoxemia and hypercapnia. | |||
==Bronchiectasis Natural History, Complications, and Prognosis== | ==Bronchiectasis Natural History, Complications, and Prognosis== | ||
| Line 18: | Line 18: | ||
*Good nutrition,ideal body weight, and regular vaccinations correlate with improved survival | *Good nutrition,ideal body weight, and regular vaccinations correlate with improved survival | ||
==References== | |||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 12:59, 25 June 2015
|
Bronchiectasis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Bronchiectasis natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of Bronchiectasis natural history, complications and prognosis |
|
FDA on Bronchiectasis natural history, complications and prognosis |
|
CDC on Bronchiectasis natural history, complications and prognosis |
|
Bronchiectasis natural history, complications and prognosis in the news |
|
Blogs on Bronchiectasis natural history, complications and prognosis |
|
Risk calculators and risk factors for Bronchiectasis natural history, complications and prognosis |
Overview
Bronchiectasis shows a higher mortality with males, advanced age, poor functional status, severe disease based on radiographic findings, and evidence of hypoxemia and hypercapnia.
Bronchiectasis Natural History, Complications, and Prognosis
- Bronchiectasis has been shown to contribute to early mortality.[1]
- Factors associated with higher mortality were advanced age, poor functional status, more severe disease based on radiographic findings, and evidence of hypoxemia or hypercapnia.
- In US long-term cohort of 91 patients, 30% died during a 13-year follow-up period (median age 60 years).[1]
- Early mortality was associated with male sex.[1]
- Bronchiectasis related to Pseudomonas aeruginosa, severe exacerbations, systemic inflammation are associated with disease progression
- 10% of adults with bronchiectasis die within 5-8 years of diagnosis, majority with the cause of death being respiratory related
- Good nutrition,ideal body weight, and regular vaccinations correlate with improved survival
References
- ↑ 1.0 1.1 1.2 McDonnell MJ, Ward C, Lordan JL, Rutherford RM (2013). "Non-cystic fibrosis bronchiectasis". QJM. 106 (8): 709–15. doi:10.1093/qjmed/hct109. PMID 23728208.